Value-based purchasing and readmission hold-backs have landed, and many providers likely don’t have a real firm grasp at how much money is at risk, said Raj Lakhanpal, M.D., CEO at SpectraMD USA, during a presentation at HIMSS13 in New Orleans.

The incremental hold-backs for the CMS value-based purchasing program and high rates of preventable readmissions incrementally increase through 2017. In addition, the weights for certain value-based purchasing measures change over time, so by 2017 the hold-back amount is weighted more heavily for clinical efficiency (cost) and eight patient satisfaction measures (the HCAHPS, collectively).

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access